Effects of nanoparticle surface-coupled peptides, functional endgroups, and charge on intracellular distribution and functionality of human primary reticuloendothelial cells

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 8, Issue 8, 2012, Pages 1282-1292

  Bartneck, Matthias ^a   Keul, Heidrun A ^b   Wambach, Mona ^b   Bornemann, Jörg ^a   Gbureck, Uwe ^c   Chatain, Nico ^a   Neuss, Sabine ^a   Tacke, Frank ^a   Groll, Jürgen ^c   Zwadlo Klarwasser, Gabriele ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Dendritic cells; Endothelial cells; Gold nanorods; Macrophages; Peptides

Indexed keywords

ANTIGEN PROCESSING; CELL FUNCTIONS; CHARGED FUNCTIONAL GROUPS; CYTOKINES; DENDRITIC CELLS; END-GROUPS; GOLD NANOROD; INTRACELLULAR DISTRIBUTION; MEDICAL USE; PEPTIDE SEQUENCES; POSITIVELY CHARGED; RETICULOENDOTHELIAL SYSTEMS; SUBCELLULAR DISTRIBUTION;

ENDOTHELIAL CELLS; FUNCTIONAL GROUPS; GOLD; MACROPHAGES; NANOPARTICLES; NANORODS; PEPTIDES; PLASMONS;

CYTOLOGY;

ARGINYLGLYCYLASPARTIC ACID; CETRIMIDE; CXCL9 CHEMOKINE; FUNCTIONAL GROUP; GAMMA INTERFERON; GLYCYLLEUCYLPHENYLALANINE; GOLD NANOPARTICLE; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MACROGOL; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; NANOPARTICLE; NANOROD; TRIPEPTIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; CELL FUNCTION; CELL MATURATION; CELLULAR DISTRIBUTION; CYTOKINE RELEASE; DENDRITIC CELL; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MACROPHAGE; MONOCYTE; PROTEIN EXPRESSION; RETICULOENDOTHELIAL SYSTEM;

ANTIGEN PRESENTATION; CYTOKINES; DENDRITIC CELLS; ENDOTHELIAL CELLS; GOLD; HUMANS; MACROPHAGES; MONOCYTES; NANOPARTICLES; NANOTUBES;

EID: 84867846149     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2012.02.012     Document Type: Article

References (37)

1. Tong L., Wei Q., Wei A., Cheng J.X. Gold nanorods as contrast agents for biological imaging: optical properties, surface conjugation and photothermal effects. Photochem Photobiol 2009, 85:21-32.
2. Huff T.B., Tong L., Zhao Y., Hansen M.N., Cheng J.X., Wei A. Hyperthermic effects of gold nanorods on tumor cells. Nanomedicine (Lond) 2007, 2:125-132.
3. Gref R., Luck M., Quellec P., Marchand M., Dellacherie E., Harnisch S., et al. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 2000, 18:301-313.
4. Maeda H. Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem 2010, 21:797-802.
5. Holback H., Yeo Y. Intratumoral drug delivery with nanoparticulate carriers. Pharm Res 2011.
6. Huang X., Peng X., Wang Y., Shin D.M., El-Sayed M.A., Nie S. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 2010, 4:5887-5896.
7. Tagalakis A.D., Grosse S.M., Meng Q.H., Mustapa M.F., Kwok A., Salehi S.E., et al. Integrin-targeted nanocomplexes for tumour specific delivery and therapy by systemic administration. Biomaterials 2011, 32:1370-1376.
8. Eghtedari M., Liopo A.V., Copland J.A., Oraevsky A.A., Motamedi M. Engineering of hetero-functional gold nanorods for the in vivo molecular targeting of breast cancer cells. Nano Lett 2009, 9:287-291.
9. Bartneck M., Keul H.A., Singh S., Czaja K., Bornemann J., Bockstaller M., et al. Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry. ACS Nano 2010, 4:3073-3086.
10. Clawson C., Huang C.T., Futalan D., Martin Seible D., Saenz R., Larsson M., et al. Delivery of a peptide via poly(D,L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity. Nanomedicine 2010, 6:651-661.
11. Steinbach F., Krause B., Blass S., Burmester G.R., Hiepe F. Development of accessory phenotype and function during the differentiation of monocyte-derived dendritic cells. Res Immunol 1998, 149:627-632.
12. Delamarre L., Pack M., Chang H., Mellman I., Trombetta E.S. Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate. Science 2005, 307:1630-1634.
13. Savina A., Amigorena S. Phagocytosis and antigen presentation in dendritic cells. Immunol Rev 2007, 219:143-156.
14. Radzicka A., Wolfenden R. A proficient enzyme. Science 1995, 267:90-93.
15. Engel P., Tedder T.F. New CD from the B cell section of the fifth international workshop on human leukocyte differentiation antigens. Leuk Lymphoma 1994, 13(Suppl 1):61-64.
16. Hunger R.E., Sieling P.A., Ochoa M.T., Sugaya M., Burdick A.E., Rea T.H., et al. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells. J Clin Invest 2004, 113:701-708.
17. Palucka K.A., Taquet N., Sanchez-Chapuis F., Gluckman J.C. Dendritic cells as the terminal stage of monocyte differentiation. J Immunol 1998, 160:4587-4595.
18. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433.
19. Jaziri M., Migliore-Samour D., Casabianca-Pignede M.R., Keddad K., Morgat J.L., Jolles P. Specific binding sites on human phagocytic blood cells for Gly-Leu-Phe and Val-Glu-Pro-Ile-Pro-Tyr, immunostimulating peptides from human milk proteins. Biochim Biophys Acta 1992, 1160:251-261.
20. Nikoobakht B., El-Sayed M.A. Preparation and growth mechanism of gold nanorods (NRs) using seed-mediated growth method. Chem Mater 2003, 15:1957-1962.
21. Gimbrone M.A., Cotran R.S., Folkman J. Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol 1974, 60:673-684.
22. Jonuleit H., Kuhn U., Muller G., Steinbrink K., Paragnik L., Schmitt E., et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997, 27:3135-3142.
23. Jacobs J.J., Lehe C.L., Hasegawa H., Elliott G.R., Das P.K. Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration. Exp Dermatol 2006, 15:432-440.
24. Sadauskas E., Wallin H., Stoltenberg M., Vogel U., Doering P., Larsen A., et al. Kupffer cells are central in the removal of nanoparticles from the organism. Part Fibre Toxicol 2007, 4:10.
25. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995, 182:389-400.
26. Koike E., Takano H., Inoue K., Yanagisawa R., Kobayashi T. Carbon black nanoparticles promote the maturation and function of mouse bone marrow-derived dendritic cells. Chemosphere 2008, 73:371-376.
27. Osaka T., Nakanishi T., Shanmugam S., Takahama S., Zhang H. Effect of surface charge of magnetite nanoparticles on their internalization into breast cancer and umbilical vein endothelial cells. Colloids Surf B Biointerfaces 2009, 71:325-330.
28. Langeggen H., Namork E., Johnson E., Hetland G. HUVEC take up opsonized zymosan particles and secrete cytokines IL-6 and IL-8 in vitro. FEMS Immunol Med Microbiol 2003, 36:55-61.
29. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008, 8:958-969.
30. Kawai J., Inaba K., Komatsubara S., Hirayama Y., Naito K., Muramatsu S. Role of macrophages as modulators but not as autonomous accessory cells in the proliferative response of immune T cells to soluble antigen. Cell Immunol 1987, 109:1-11.
31. Zupke O., Distler E., Baumann D., Strand D., Meyer R.G., Landfester K., et al. Preservation of dendritic cell function upon labeling with amino functionalized polymeric nanoparticles. Biomaterials 2010, 31:7086-7095.
32. Vallelian F., Schaer C.A., Kaempfer T., Gehrig P., Duerst E., Schoedon G., et al. Glucocorticoid treatment skews human monocyte differentiation into a hemoglobin-clearance phenotype with enhanced heme-iron recycling and antioxidant capacity. Blood 2010, 116:5347-5356.
33. Taront S., Dieudonne A., Blanchard S., Jeannin P., Lassalle P., Delneste Y., et al. Implication of scavenger receptors in the interactions between diesel exhaust particles and immature or mature dendritic cells. Part Fibre Toxicol 2009, 6:9.
34. Melgarejo E., Medina M.A., Sanchez-Jimenez F., Urdiales J.L. Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol 2009, 41:998-1001.
35. Castellino F., Huang A.Y., Altan-Bonnet G., Stoll S., Scheinecker C., Germain R.N. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature 2006, 440:890-895.
36. Kryczek I., Banerjee M., Cheng P., Vatan L., Szeliga W., Wei S., et al. Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 2009, 114:1141-1149.
37. Martin D., Galisteo R., Gutkind J.S. CXCL8/IL8 stimulates vascular endothelial growth factor (VEGF) expression and the autocrine activation of VEGFR2 in endothelial cells by activating NFkappaB through the CBM (Carma3/Bcl10/Malt1) complex. J Biol Chem 2009, 284:6038-6042.